Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study).

about

Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study).

Item

http://www.wikidata.org/entity/Q46850739

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Exploring venlafaxine pharmaco ...... ch-swiss study (MARVEL study).

@en

Exploring venlafaxine pharmaco ...... ch-swiss study (MARVEL study).

@nl

type

Item

label

Exploring venlafaxine pharmaco ...... ch-swiss study (MARVEL study).

@en

Exploring venlafaxine pharmaco ...... ch-swiss study (MARVEL study).

@nl

prefLabel

Exploring venlafaxine pharmaco ...... ch-swiss study (MARVEL study).

@en

Exploring venlafaxine pharmaco ...... ch-swiss study (MARVEL study).

@nl

P1476

Exploring venlafaxine pharmaco ...... ch-swiss study (MARVEL study).

@en

P2093

Antoine Yrondi

http://www.w3.org/2001/XMLSchema#string

Célia Lloret-Linares

http://www.w3.org/2001/XMLSchema#string

Damien Montange

http://www.w3.org/2001/XMLSchema#string

Fabienne Calvas

http://www.w3.org/2001/XMLSchema#string

Fanny Molière

http://www.w3.org/2001/XMLSchema#string

Florence Galtier

http://www.w3.org/2001/XMLSchema#string

Isabelle Nieto

http://www.w3.org/2001/XMLSchema#string

Jean-Luc Cracowski

http://www.w3.org/2001/XMLSchema#string

Jerôme Holtzmann

http://www.w3.org/2001/XMLSchema#string

Jules Desmeules

http://www.w3.org/2001/XMLSchema#string

P2860

Personalized medicine in major depressive disorder -- opportunities and pitfalls

Applications of CYP450 testing in the clinical setting

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Venlafaxine extended-release: a review of its use in the management of major depression

O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants

Venlafaxine serum levels and CYP2D6 genotype

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

Treatment resistant depression: methodological overview and operational criteria.

New strategies for treating chronic depression.

P2888

s40360-017-0173-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40360-017-0173-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frédéric Haesebaert

Frank Bellivier

Marion Leboyer

Philippe Le Corvoisier

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092578276

http://www.w3.org/2001/XMLSchema#string

P698

29115994

http://www.w3.org/2001/XMLSchema#string

P932

5678760

http://www.w3.org/2001/XMLSchema#string